{"id":833533,"date":"2025-04-03T09:19:22","date_gmt":"2025-04-03T13:19:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/"},"modified":"2025-04-03T09:19:22","modified_gmt":"2025-04-03T13:19:22","slug":"globus-medical-completes-acquisition-of-nevro-corp","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/","title":{"rendered":"Globus Medical completes acquisition of Nevro Corp."},"content":{"rendered":"
\n

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) — Globus Medical, Inc.\u00a0(NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain.<\/p>\n

\u201cWe are excited to begin the journey of accelerating market penetration of Nevro\u2019s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering from chronic pain,\u201d said\u00a0Dan Scavilla, president and CEO of\u00a0Globus Medical.<\/p>\n

The acquisition of Nevro further expands Globus Medical’s presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to its product portfolio with the potential to alter the standard of care in the neuromodulation space and beyond.<\/p>\n

Globus Medical\u00a0plans to discuss the closing of the acquisition and the anticipated benefits of the expanded product offering during its first quarter earnings conference in May.<\/p>\n

Nevro Corp. common stock ceased trading on the New York Stock Exchange prior to the open of the market on\u00a0April 3, 2025. Further information about the transaction can be found in the Form 8-Ks filed with the\u00a0SEC\u00a0today by Nevro Corp. and\u00a0Globus Medical, respectively.<\/p>\n

\n Financial and\u00a0Legal Advisors<\/strong>
\n
Morgan Stanley & Co. LLC served as financial advisor to Globus Medical,\u00a0and\u00a0Wyrick Robbins Yates & Ponton LLP\u00a0served as legal advisor. BofA Securities, Inc. served as financial advisor to Nevro Corp.\u00a0and\u00a0Latham & Watkins LLP\u00a0served as legal advisor.<\/p>\n

\n About Globus Medical, Inc.<\/strong>
\n
Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at https:\/\/www.globusmedical.com\/<\/a>.<\/p>\n

\n About Nevro Corp.<\/strong>
\n
Headquartered in Redwood City, California, Nevro Corp. is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in the treatment of chronic pain. Nevro\u2019s comprehensive HFX\u2122 spinal cord stimulation (SCS) platform includes the Senza\u00ae<\/sup> SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. Nevro also provides minimally invasive treatment options for patients suffering from chronic sacroiliac joint pain.<\/p>\n

\n Safe Harbor Statements\u00a0<\/strong>
\n
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as \u201cbelieve,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201ccould,\u201d \u201cwill,\u201d \u201caim,\u201d \u201cestimate,\u201d \u201ccontinue,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cexpect,\u201d \u201cplan\u201d and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of the\u00a0Nevro\u00a0business, trends in the medical industry and the ability of\u00a0Globus Medical\u00a0and\u00a0Nevro\u00a0to: (i) successfully integrate and achieve anticipated synergies, (ii) manage our growth, (iii) sustain profitability, (iv) sustain demand for products, (v) compete successfully (including without limitation success in convincing surgeons to use\u00a0Globus Medical\u00a0or\u00a0Nevro\u00a0products and the ability to attract and retain sales and other personnel), (vi) rapidly develop and introduce new products, (vii) develop and execute successful business strategies, (viii) comply with changes and applicable laws and regulations that are or may become applicable to\u00a0Globus Medical\u00a0and\/or\u00a0Nevro, (ix) safeguard our intellectual property, and (x) succeed in defending against legal proceedings in addition to general economic conditions and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, refer to the disclosure of each\u00a0of Globus Medical\u00a0and\u00a0Nevro\u00a0contained in each company\u2019s most recent annual report on Form 10-K filed with the\u00a0U.S. Securities and Exchange Commission, including the sections labeled \u201cRisk Factors\u201d and \u201cCautionary Note Concerning Forward-Looking Statements,\u201d and in each company\u2019s Forms 10-Q, Forms 8-K and other filings with the\u00a0U.S. Securities and Exchange Commission. These documents are available at\u00a0www.sec.gov<\/a>. Moreover, each of\u00a0Globus Medical\u00a0and\u00a0Nevro\u00a0operates in an evolving environment. New risk factors and uncertainties emerge from time to time, and it is not possible for\u00a0Globus Medical\u00a0and\u00a0Nevro\u00a0to predict all risk factors and uncertainties, nor can we assess the impact of all factors on the\u00a0Globus Medical\u00a0business and\u00a0Nevro\u00a0business, respectively, or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release.\u00a0Globus Medical\u00a0and\u00a0Nevro\u00a0undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.\u00a0\u00a0<\/p>\n

\n Investor contact:<\/strong>
\n
Brian Kearns
610-930-1800
investors@globusmedical.com<\/a><\/p>\n

\n Media contact:<\/strong>
\n
Moran Chavez
media@globusmedical.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) — Globus Medical, Inc.\u00a0(NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain. \u201cWe are excited to begin the journey of accelerating market penetration of Nevro\u2019s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering from chronic pain,\u201d said\u00a0Dan Scavilla, president and CEO of\u00a0Globus Medical. The acquisition of Nevro further expands Globus Medical’s presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to its product portfolio with the potential to alter the standard of … <\/p>\n

Continue reading “Globus Medical completes acquisition of Nevro Corp.”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-833533","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGlobus Medical completes acquisition of Nevro Corp. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Globus Medical completes acquisition of Nevro Corp. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) — Globus Medical, Inc.\u00a0(NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain. \u201cWe are excited to begin the journey of accelerating market penetration of Nevro\u2019s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering from chronic pain,\u201d said\u00a0Dan Scavilla, president and CEO of\u00a0Globus Medical. The acquisition of Nevro further expands Globus Medical’s presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to its product portfolio with the potential to alter the standard of … Continue reading "Globus Medical completes acquisition of Nevro Corp."\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-03T13:19:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQyNiM2ODQ4OTM2IzIwMDg4MjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Globus Medical completes acquisition of Nevro Corp.\",\"datePublished\":\"2025-04-03T13:19:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/\"},\"wordCount\":885,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNjQyNiM2ODQ4OTM2IzIwMDg4MjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/\",\"name\":\"Globus Medical completes acquisition of Nevro Corp. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNjQyNiM2ODQ4OTM2IzIwMDg4MjQ=\",\"datePublished\":\"2025-04-03T13:19:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNjQyNiM2ODQ4OTM2IzIwMDg4MjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNjQyNiM2ODQ4OTM2IzIwMDg4MjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/globus-medical-completes-acquisition-of-nevro-corp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Globus Medical completes acquisition of Nevro Corp.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Globus Medical completes acquisition of Nevro Corp. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/","og_locale":"en_US","og_type":"article","og_title":"Globus Medical completes acquisition of Nevro Corp. - Market Newsdesk","og_description":"AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) — Globus Medical, Inc.\u00a0(NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain. \u201cWe are excited to begin the journey of accelerating market penetration of Nevro\u2019s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering from chronic pain,\u201d said\u00a0Dan Scavilla, president and CEO of\u00a0Globus Medical. The acquisition of Nevro further expands Globus Medical’s presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to its product portfolio with the potential to alter the standard of … Continue reading \"Globus Medical completes acquisition of Nevro Corp.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-03T13:19:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQyNiM2ODQ4OTM2IzIwMDg4MjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Globus Medical completes acquisition of Nevro Corp.","datePublished":"2025-04-03T13:19:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/"},"wordCount":885,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQyNiM2ODQ4OTM2IzIwMDg4MjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/","name":"Globus Medical completes acquisition of Nevro Corp. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQyNiM2ODQ4OTM2IzIwMDg4MjQ=","datePublished":"2025-04-03T13:19:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQyNiM2ODQ4OTM2IzIwMDg4MjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNjQyNiM2ODQ4OTM2IzIwMDg4MjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/globus-medical-completes-acquisition-of-nevro-corp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Globus Medical completes acquisition of Nevro Corp."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=833533"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/833533\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=833533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=833533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=833533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}